SEC Form 4 · accession 0001181431-15-007196
DAVITA INC. · DVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael David Staffieri
Officer — COO, Kidney Care
Period of report
May 15, 2015
Accepted (ET)
May 19, 2015 · 9:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000927066
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 15, 2015 | A | 9,868 | $0.00 | A | 10,262 | D | |
| Common StockF2,F3 | May 18, 2015 | S | 2,047 | $82.0277 | D | 8,215 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares received upon the satisfaction of performance criteria underlying the awards of performance units.
- F2Represents the weighted average sale price of $82.0277. The range of prices for the sale of these shares was $82.02 - $82.04, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
- F3Includes 394 shares acquired under Issuer's employee stock purchase plan on 12/31/2014.